Based on the above PAM subgroups (Supplementary Figure S1), we removed subjects with the same subgroup of diseases for each of the three diseases, and 2,542 subjects with AST, 3,252 subjects with HPT, and 7,058 subjects with IBS were excluded. This evidence concerns the gene MRS2 and irritable bowel syndrome.